Sinopharm Tech Holdings (HKSE:08156) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08156 Sinopharm Tech Holdings Ltd HKSE:08156
27 GF Score
Price HK$0.16
GF Value HK$0.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sinopharm Tech Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sinopharm Tech Holdings Valuation Rank Related Terms

HKSE:08156
27GF Score
Sinopharm Tech Holdings Ltd HKSE:08156
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued. The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06. GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:08156:

  • Valuation Rank:
  • GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinopharm Tech Holdings Business Description

Address Ruttonjee Centre, 11 Duddell Street Central, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score

Get the complete analysis for HKSE:08156

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.06
GF Value